The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...

The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...

The U.S. Food and Drug Administration has now put a handful of recalled chocolate snack products at the agency’s highest risk ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

According to the FDA, If consumers have an allergy or sensitivity to milk, they should not consume the product and discard it ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

A broccoli product sold at Walmart in Michigan was under recall. Now the FDA says the product may be considered deadly.

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...

The U.S. Food and Drug Administration has labeled the broccoli recall as a Class I, the highest risk level issued by the ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...